DocDollars

Ptc Therapeutics, Inc.

NJ · United States · Reporting entity ID 100000191753

Total reported 2019–2025
$57.7M
#154 of 2,960 reporting companies — 0.1% of all reported industry payments
$6.65M in general payments across 4,128 records, plus $51.0M in research funding across 5,584 records.

How it breaks down

General payments $6,650,209
Research funding $51,017,822

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ptc Therapeutics, Inc. reported $57.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #154 of 2,960 reporting companies. 88% of that was research funding and 12% general payments such as consulting, speaking, food and travel. 4,128 general payment records and 5,584 research records were filed.

Common questions about Ptc Therapeutics, Inc.

How much has Ptc Therapeutics, Inc. paid US doctors?

Ptc Therapeutics, Inc. reported $57,668,031 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,650,209 in general payments, $51,017,822 in research funding.

How does Ptc Therapeutics, Inc. rank among drug and device companies?

It ranks #154 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Ptc Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.